Peter Soparkar - Apr 19, 2022 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role
Chief Operating Officer and Chief Legal Officer
Signature
Peter Soparkar, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
ADVM
Transactions as of
Apr 19, 2022
Transactions value $
$24,994
Form type
4
Date filed
4/20/2022, 04:35 PM
Previous filing
Mar 17, 2022
Next filing
Sep 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADVM Common Stock Purchase $199 +175 +0.07% $1.14 259K Apr 19, 2022 Direct
transaction ADVM Common Stock Purchase $24.8K +21.8K +8.4% $1.14 281K Apr 19, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Chief Operating Officer and Chief Legal Officer